1-3 of 3
lusutrombopag
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease

Lee F. Allen, MD PhD, Kavita Aggarwal, PharmD, Michael Vredenburg, PhD, Christine Barnett, PhD, Deirdre Mladsi, BA, Ray Kim, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3454.
https://doi.org/10.1182/blood-2019-131822
Published: 2019
Journal Articles

A Systematic Review and Meta-Analysis of Safety and Efficacy for Pre-Procedural Use of Thrombopoietin Receptor Agonists in Hepatic Cirrhosis Patients

Kunhwa Kim, MDMPH, Faustine Ong, Gabor Varadi, MD, Sorab Gupta, MD, Vinicius Machado Jorge, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1094.
https://doi.org/10.1182/blood-2019-132063
Published: 2019
Journal Articles

Platelet Response to Lusutrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Non-Emergency Invasive Procedures: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Nezam Afdhal, MD, Ajay Duggal, MD, Toshimitsu Ochiai, Tomoko Motomiya, Takeshi Kano, MSc, Tsutae Nagata, MD, Markus Peck-Radosavljevic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 291.
https://doi.org/10.1182/blood.V130.Suppl_1.291.291
Published: 2017